Tianjin Medical University Cancer Institute And Hospital

This study is testing a personalized treatment plan for people with advanced, inoperable esophageal cancer. It first uses a combination of immunotherapy and chemotherapy to see how the cancer responds. Based on that response, patients then receive a tailored follow-up treatment t…

This study is testing whether a new type of immune cell therapy, called WAST cells, can help control advanced lung cancer when combined with standard chemotherapy. It's for patients whose cancer has continued to grow despite previous immunotherapy treatment. Researchers want to s…

This study aims to see if a combination of chemotherapy and radiation can be as effective as major surgery for controlling a specific type of esophageal cancer. It is for patients whose tumors shrink significantly after initial drug treatment. The goal is to determine if this les…

This study is testing if adding a new immunotherapy drug called Serplulimab to standard chemoradiotherapy is better at preventing cervical cancer from coming back after surgery. It is for patients who have had surgery but are at high risk of the cancer returning. The goal is to s…

This study is testing a new combination of three drugs and a short course of radiation given before surgery for locally advanced rectal cancer. The goal is to shrink the tumor as much as possible, ideally to the point where no cancer cells are found after surgery. The study will …

This study is testing whether a follow-up immune therapy can help prevent cancer from returning in people with advanced head and neck cancer. It is for patients who have already had initial treatment with immunotherapy and chemotherapy and whose cancer showed a strong response. T…

This study is testing a new three-drug combination (Chidamide, Rituximab, and Polatuzumab Vedotin) for elderly patients with a specific, aggressive type of lymphoma who have not yet received treatment. The main goal is to see how well this regimen works to eliminate the cancer an…

This study is testing whether adding two new immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy works better for people with metastatic pancreatic cancer. The trial will enroll 33 patients who haven't had any prior cancer treatment to see if this combinat…

This study is for people with a specific type of lung cancer (non-small cell) who had surgery after initial treatment, but some cancer cells likely remain. It tests whether adding a personalized cell therapy (L-TIL), made from the patient's own immune cells, to a standard immunot…

This study is testing if adding more chemotherapy to a standard treatment plan improves outcomes for women with locally advanced cervical cancer. It will compare two groups: one receiving immunotherapy plus radiation, and another receiving extra chemotherapy cycles on top of that…

This early-stage study is testing a new cell therapy called GK01, given alone or with chemotherapy, after surgery to remove solid tumors. The main goal is to see if the treatment is safe and how the body handles it in adults with cancers like pancreatic, bile duct, or stomach can…

This study is testing a combination of three treatments for a severe form of lung cancer that has spread to the brain and its protective lining. It will involve 30 adults with a specific genetic marker (EGFR mutation) who have not yet received treatment for their advanced cancer.…

This study is testing if a capsule drug called anlotinib can help prevent lung cancer from returning in patients who have had surgery. It is for people with non-small cell lung cancer who still had cancer cells present after their initial treatment. The main goal is to see if the…

This study is testing whether adding a new immunotherapy drug called Iparomlimab helps control cancer better for older patients (70+) with inoperable esophageal cancer. After patients finish standard chemotherapy and radiation, they will receive the immunotherapy drug for one yea…

This study is testing if it is safe for some breast cancer patients to skip surgery. It is for women with triple negative or HER2+ breast cancer who have no visible cancer left after completing chemotherapy and radiation. The main goal is to see if these patients can have the sam…

This study is testing whether adding two immunotherapy drugs (serplulimab and nimotuzumab) to standard chemotherapy and radiation before surgery is safe and more effective for patients with locally advanced esophageal cancer. The goal is to shrink the tumor as much as possible be…

This study is testing whether a nasal spray given before surgery can help patients feel calmer and more comfortable during breast-conserving cancer surgery. Researchers will compare the spray to a placebo (saltwater spray) in about 394 women to see if it reduces anxiety, improves…

This study aims to see if the types of bacteria found inside digestive system tumors can help predict which patients will benefit from pre-surgery (neoadjuvant) cancer treatment. Researchers will collect tumor samples from 90 patients with cancers like stomach, pancreatic, or col…

This study aims to better understand how stomach cancer spreads to nearby lymph nodes. Researchers will observe 400 patients undergoing surgery for advanced lower stomach cancer to see which specific lymph node areas are most often affected. The goal is to gather information that…

This study observes how patients with a common type of advanced breast cancer respond to standard first-line drug combinations and what treatments doctors choose next when those drugs stop working. It involves about 245 patients already receiving care, collecting their real-world…